Sherpa Venture Capital is an investment firm that focuses on the investment and cultivation of the Pharmaceutical and Biotech industry.
Sherpa Venture Capital is an investment firm that focuses on the investment and cultivation of the Pharmaceutical and Biotech industry. It also specializes in the investment and management of sector leaders and innovators within the Pharma, GeneTech, MedTech, Medical services, and various sub-sectors, where they have established robust portfolio sources, lasting value-adding cooperations and relationships, as well as mature all-cycle services with key resources. It was founded in 2018 and is headquartered in Beijing, China.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Jun 20, 2022
Yuanyin Bio
|
Series A | ¥280M | Biopharma | — |
Jul 27, 2021
Hongyun Biotech
|
Series B | ¥100M | Biotechnology | — |
Mar 22, 2021
EpimAb Biotherapeutics
|
Series C | $120M | Biopharma | — |
Feb 28, 2020
Hongyun Biotech
|
Series A | ¥50M | Biotechnology | — |
Sep 9, 2019
GKHT Medical Technology
|
Series C | ¥1.10B | Health Care | — |